VC Catalog · venture ecosystem research library
VC Catalog home Beta

Company

NKIO

Rocket Ship RatingBased on the data VC Catalog holds.

Rocket Ship Rating: 79 out of 100

Unlocking the potential of human Natural Killer cells.

Also known as NK:IO

  • Biotech & therapeutics
  • Deeptech
Status
Operatingas of 2026-09-17
Business model
B2B
Open relationship map
Claim, correct or request removal

Record updated 28 September 2026

About

NK:IO reimagines cancer treatment. By harnessing the potential of the innate immune system, we are developing ground breaking NK cell and small molecule therapies targeting both haematological and solid tumours.

Funding snapshot

Latest round
Grant2023-07-11

Funding rounds

Grant
2023-07-11
Seed
Recorded
Loading relationship preview

Cookies on VC Catalog

We use necessary cookies to run the site (sign-in, security, remembering this choice). With your permission we also use Google Analytics to understand how the site is used. Analytics cookies are set only if you accept all cookies. Privacy policy